Richard E. Kuntz M.D., M.Sc.
Net Worth

Last updated:

What is Richard E. Kuntz M.D., M.Sc. net worth?

The estimated net worth of Dr. Richard E. Kuntz M.D., M.Sc. is at least $63,000,356 as of 24 Dec 2019. He owns shares worth $6,660,659 as insider, has earned $30,239,697 from insider trading and has received compensation worth at least $26,100,000 in Medtronic plc.

What is the salary of Richard E. Kuntz M.D., M.Sc.?

Dr. Richard E. Kuntz M.D., M.Sc. salary is $2,610,000 per year as Senior Vice President and Chief Medical & Scientific Officer in Medtronic plc.

How old is Richard E. Kuntz M.D., M.Sc.?

Dr. Richard E. Kuntz M.D., M.Sc. is 68 years old, born in 1957.

What stocks does Richard E. Kuntz M.D., M.Sc. currently own?

As insider, Dr. Richard E. Kuntz M.D., M.Sc. owns shares in one company:

Company Title Shares Price per share Total value
Medtronic plc (MDT) Senior Vice President and Chief Medical & Scientific Officer 74,032 $89.97 $6,660,659

What does Medtronic plc do?

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Richard E. Kuntz M.D., M.Sc. insider trading

Medtronic plc

Dr. Richard E. Kuntz M.D., M.Sc. has made 13 insider trades between 2015-2019, according to the Form 4 filled with the SEC. Most recently he sold 8,086 units of MDT stock worth $918,853 on 24 Dec 2019.

The largest trade he's ever made was exercising 81,364 units of MDT stock on 9 Jan 2018. As of 24 Dec 2019 he still owns at least 74,032 units of MDT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Ordinary Shares 8,086 $113.64 $918,853
Option
Stock Option (Right to Buy) 2,404 $41.6 $100,006
Option
Ordinary Shares 42,770 $89.61 $3,832,491
Sale
Ordinary Shares 21,425 $107.86 $2,310,922
Sale
Ordinary Shares 5,719 $102.02 $583,452
Sale
Ordinary Shares 3,438 N/A N/A
Sale
Ordinary Shares 47,176 $95.88 $4,523,093
Option
Stock Option (Right to Buy) 41,227 $38.81 $1,600,020
Option
Ordinary Shares 41,227 $38.81 $1,600,020
Sale
Ordinary Shares 11,500 $87.13 $1,001,995
Sale
Ordinary Shares 78,526 $86.21 $6,769,726
Option
Ordinary Shares 81,364 $36.21 $2,945,784
Option
Stock Option (Right to Buy) 35,492 $37.53 $1,332,015
Sale
Ordinary Shares 17,141 $86.7 $1,486,056
Sale
Ordinary Shares 25,199 $86.67 $2,183,997
Option
Stock Option (Right to Buy) 30,624 $35.92 $1,100,014
Option
Ordinary Shares 30,624 $35.92 $1,100,014
Option
Ordinary Shares 58,900 $42.01 $2,474,095
Sale
Ordinary Shares 49,905 $82.6 $4,122,153
Option
Stock Option (Right to Buy) 23,028 $47.77 $1,100,048
Sale
Ordinary Shares 4,000 $75.22 $300,880
Sale
Ordinary Shares 13,715 $78.06 $1,070,648
Option
Ordinary Shares 15,401 $48.7 $750,029
Option
Employee Stock Option (right to buy) 15,401 $48.7 $750,029
Option
Employee Stock Option (right to buy) 18,703 $53.47 $1,000,049
Sale
Ordinary Shares 64,190 $77.39 $4,967,921
Option
Ordinary Shares 35,447 $55.11 $1,953,307

Medtronic key executives

Medtronic plc executives and other stock owners filed with the SEC: